1. What are the two parts of the Drug Quality and Security Act?
A. The Compounding Quality Act and Drug Supply Chain Security Act
B. The Product Tracing Act and Drug Supply Chain Security Act
C. The Third Party Licensing and Standards and the Product Tracing Act
D. The Non-sterile Compounding Act and the Pharmaceutical Source Act
2. Pharmaceutical crime incidents increased by _______ from 2017 to 2018.
A. 5%
B. 10%
C. 25%
D. 45%
3. According to DSCSA goals, an interoperable, electronic tracing of products at the package level will be implemented by which year?
A. 2020
B. 2023
C. 2025
D. 2030
4. Products that are NOT covered in the scope of the DSCSA include:
A. Brand name drugs
B. Generic drugs
C. Schedule II-V drugs
D. Biologics
5. Buyers must store the transaction information, transaction history, and transaction statement for each transaction for what amount of time?
A. 6 months
B. 2 years
C. 6 years
D. 10 years
6. What is traceability?
A. Traceability establishes national system for tracing pharmaceutical products through the supply chain
B. Traceability sets national licensing standards for wholesaler distributors and third-party logistics companies
C. Traceability preempts all state laws and regulations for pedigree requirements
D. Traceability sets state laws on wholesale and third-party logistics licensure
7. Exemptions to DSCSA requirements include:
A. Dispensing to patients
B. Intercompany distributions
C. Public health emergencies
D. All of the above
Evaluation Questions
8. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
9. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
10. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
11. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Will the information presented cause you to change your practice?
A. Yes
B. No
20. Are you committed to making these changes?
A. Yes
B. No
21. As a result of this activity, did you learn something new?
A. Yes
B. No
22. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
23. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20